JCO-话题@MedSci

#JCO#

724篇内容 | 6953人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1891555, encodeId=ba6d18915552d, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：Pembrolizumab新辅助治疗肌层浸润性膀胱癌, objectType=article, longId=152424, objectId=e34715242443, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e34715242443, replyNumber=0, likeNumber=90, createdTime=2019-02-07, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e34715242443, moduleTitle=JCO：Pembrolizumab新辅助治疗肌层浸润性膀胱癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e34715242443)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891527, encodeId=c912189152ef8, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：免疫治疗疗效评价标准imRECIST, objectType=article, longId=143869, objectId=3a2e143869e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a2e143869e7, replyNumber=0, likeNumber=80, createdTime=2019-05-15, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a2e143869e7, moduleTitle=JCO：免疫治疗疗效评价标准imRECIST, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a2e143869e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891582, encodeId=c4b0189158276, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：认知行为疗法对乳腺癌治疗诱导的更年期症状的疗效, objectType=article, longId=160140, objectId=c046160140d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c046160140d7, replyNumber=0, likeNumber=85, createdTime=2019-04-24, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c046160140d7, moduleTitle=JCO：认知行为疗法对乳腺癌治疗诱导的更年期症状的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c046160140d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891574, encodeId=a10c18915e479, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：功能修复分析帮助诊断非肿瘤组织的错配修复缺陷, objectType=article, longId=157424, objectId=049415e424e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=049415e424e7, replyNumber=0, likeNumber=84, createdTime=2019-05-27, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=049415e424e7, moduleTitle=JCO：功能修复分析帮助诊断非肿瘤组织的错配修复缺陷, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=049415e424e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891546, encodeId=57e41891546e1, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：紫杉醇联合LCL161治疗三阴性乳腺癌, objectType=article, longId=149301, objectId=e301149301c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e301149301c0, replyNumber=0, likeNumber=77, createdTime=2019-05-14, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e301149301c0, moduleTitle=JCO：紫杉醇联合LCL161治疗三阴性乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e301149301c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891540, encodeId=6cf918915403e, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：尼日利亚女性乳腺癌遗传特征, objectType=article, longId=147353, objectId=cc8614e3533f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc8614e3533f, replyNumber=0, likeNumber=81, createdTime=2018-10-31, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc8614e3533f, moduleTitle=JCO：尼日利亚女性乳腺癌遗传特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc8614e3533f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891523, encodeId=ead618915238a, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：替莫唑胺治疗小细胞肺癌：随机双盲研究, objectType=article, longId=140935, objectId=3b6114093543, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b6114093543, replyNumber=0, likeNumber=75, createdTime=2018-07-23, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b6114093543, moduleTitle=JCO：替莫唑胺治疗小细胞肺癌：随机双盲研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b6114093543)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891583, encodeId=62411891583f7, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：PROSTVAC在转移性去势抵抗性前列腺癌中的III期试验, objectType=article, longId=161545, objectId=3b1a161545a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b1a161545a9, replyNumber=0, likeNumber=75, createdTime=2019-03-16, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b1a161545a9, moduleTitle=JCO：PROSTVAC在转移性去势抵抗性前列腺癌中的III期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b1a161545a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891538, encodeId=6de9189153861, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：恶性间皮瘤肿瘤易感基因的突变频率, objectType=article, longId=147191, objectId=24d914e191c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24d914e191c9, replyNumber=0, likeNumber=57, createdTime=2018-12-26, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24d914e191c9, moduleTitle=JCO：恶性间皮瘤肿瘤易感基因的突变频率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24d914e191c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891524, encodeId=b3a51891524a8, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：达克替尼一线用于EGFR突变NSCLC患者，生存期达34.1个月（ARCHER 1050研究）, objectType=article, longId=141439, objectId=d96a141439e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d96a141439e2, replyNumber=0, likeNumber=92, createdTime=2019-01-11, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d96a141439e2, moduleTitle=JCO：达克替尼一线用于EGFR突变NSCLC患者，生存期达34.1个月（ARCHER 1050研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d96a141439e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891534, encodeId=e2c7189153402, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：局部晚期食管鳞状细胞癌新辅助放化疗联合手术与单纯手术治疗效果比较, objectType=article, longId=146659, objectId=18ba1466595a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18ba1466595a, replyNumber=0, likeNumber=121, createdTime=2019-05-16, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18ba1466595a, moduleTitle=JCO：局部晚期食管鳞状细胞癌新辅助放化疗联合手术与单纯手术治疗效果比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18ba1466595a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891587, encodeId=9c97189158eb5, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：癌症幸存女童的乳腺癌患病情况, objectType=article, longId=165944, objectId=e5e41659446f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5e41659446f, replyNumber=0, likeNumber=72, createdTime=2019-07-08, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5e41659446f, moduleTitle=JCO：癌症幸存女童的乳腺癌患病情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5e41659446f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891568, encodeId=ffd71891568c7, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：普瑞巴林治疗头颈部肿瘤患者放疗相关神经性疼痛, objectType=article, longId=154709, objectId=5da0154e0955, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5da0154e0955, replyNumber=0, likeNumber=76, createdTime=2019-07-07, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5da0154e0955, moduleTitle=JCO：普瑞巴林治疗头颈部肿瘤患者放疗相关神经性疼痛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5da0154e0955)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891539, encodeId=841e18915390e, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：Nivolumab和Nivolumab联合Ipilimumab治疗转移性食管胃癌患者, objectType=article, longId=147192, objectId=187c14e1923f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=187c14e1923f, replyNumber=0, likeNumber=75, createdTime=2019-06-03, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=187c14e1923f, moduleTitle=JCO：Nivolumab和Nivolumab联合Ipilimumab治疗转移性食管胃癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=187c14e1923f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891561, encodeId=48061891561e1, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：Pembrolizumab治疗具有脑转移的黑色素瘤：II期临床, objectType=article, longId=153201, objectId=ee2f15320164, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee2f15320164, replyNumber=0, likeNumber=66, createdTime=2019-03-18, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee2f15320164, moduleTitle=JCO：Pembrolizumab治疗具有脑转移的黑色素瘤：II期临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee2f15320164)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891537, encodeId=bffa189153e45, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：基线类固醇对非小细胞肺癌患者PD-1/PD-L1阻断治疗有效性的影响, objectType=article, longId=147190, objectId=3dc814e1907e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dc814e1907e, replyNumber=0, likeNumber=69, createdTime=2019-04-15, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dc814e1907e, moduleTitle=JCO：基线类固醇对非小细胞肺癌患者PD-1/PD-L1阻断治疗有效性的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3dc814e1907e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891585, encodeId=38271891585e8, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：恶性胸膜间皮瘤患者预防性照射：开放标签，多中心，III期随机临床试验, objectType=article, longId=163282, objectId=405216328246, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=405216328246, replyNumber=0, likeNumber=93, createdTime=2019-12-22, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=405216328246, moduleTitle=JCO：恶性胸膜间皮瘤患者预防性照射：开放标签，多中心，III期随机临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=405216328246)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891551, encodeId=887d189155164, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：改善结直肠癌预后从健康的饮食开始, objectType=article, longId=151968, objectId=2548151968a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2548151968a0, replyNumber=0, likeNumber=62, createdTime=2019-01-15, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2548151968a0, moduleTitle=JCO：改善结直肠癌预后从健康的饮食开始, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2548151968a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891509, encodeId=54ce189150988, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：激素治疗增加乳腺癌患者患糖尿病风险, objectType=article, longId=136506, objectId=e1d213650671, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1d213650671, replyNumber=0, likeNumber=81, createdTime=2018-11-27, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1d213650671, moduleTitle=JCO：激素治疗增加乳腺癌患者患糖尿病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1d213650671)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891543, encodeId=425f18915438a, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：Capmatinib联合Gefitinib治疗EGFR抑制失败的非小细胞肺癌患者, objectType=article, longId=147810, objectId=bbcb14e81092, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbcb14e81092, replyNumber=0, likeNumber=73, createdTime=2019-03-16, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbcb14e81092, moduleTitle=JCO：Capmatinib联合Gefitinib治疗EGFR抑制失败的非小细胞肺癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbcb14e81092)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

JCO

2020-05-29

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：Pembrolizumab新辅助治疗肌层浸润性膀胱癌

2019-02-07

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：免疫治疗疗效评价标准imRECIST

2019-05-15

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：认知行为疗法对乳腺癌治疗诱导的更年期症状的疗效

2019-04-24

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：功能修复分析帮助诊断非肿瘤组织的错配修复缺陷

2019-05-27

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：紫杉醇联合LCL161治疗三阴性乳腺癌

2019-05-14

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：尼日利亚女性乳腺癌遗传特征

2018-10-31

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：替莫唑胺治疗小细胞肺癌：随机双盲研究

2018-07-23

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：PROSTVAC在转移性去势抵抗性前列腺癌中的III期试验

2019-03-16

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：恶性间皮瘤肿瘤易感基因的突变频率

2018-12-26

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：达克替尼一线用于EGFR突变NSCLC患者，生存期达34.1个月（ARCHER 1050研究）

2019-01-11

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：局部晚期食管鳞状细胞癌新辅助放化疗联合手术与单纯手术治疗效果比较

2019-05-16

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：癌症幸存女童的乳腺癌患病情况

2019-07-08

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：普瑞巴林治疗头颈部肿瘤患者放疗相关神经性疼痛

2019-07-07

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：Nivolumab和Nivolumab联合Ipilimumab治疗转移性食管胃癌患者

2019-06-03

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：Pembrolizumab治疗具有脑转移的黑色素瘤：II期临床

2019-03-18

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：基线类固醇对非小细胞肺癌患者PD-1/PD-L1阻断治疗有效性的影响

2019-04-15

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：恶性胸膜间皮瘤患者预防性照射：开放标签，多中心，III期随机临床试验

2019-12-22

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：改善结直肠癌预后从健康的饮食开始

2019-01-15

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：激素治疗增加乳腺癌患者患糖尿病风险

2018-11-27

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：Capmatinib联合Gefitinib治疗EGFR抑制失败的非小细胞肺癌患者

2019-03-16

科室
- - 订阅+
  - 更多科室
工具
服务